Science and Research

SEAL 19999

PEGylated adrenomedullin is planned to be administered in mechanically ventilated ARDS patients by inhalation via endotracheal tube.

Study details
Study-ID: 2019-001078-27
Study-ID: 2019-001078-27
DZL Disease Area: PALI
DZL Disease Area: PALI
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL recruiting center
DZL Role: DZL recruiting center
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: BIH / Charité - Associated Partner
DZL Participating Sites: BIH / Charité - Associated Partner
Start Date: 01.07.2021
Completion Date: 16.05.2023
Status: Closed
Status: Closed
DZL recruiting center


close
chevron-down

Unsere Seite verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Mehr Informationen dazu finden Sie in unserer Datenschutzerklärung.